Our study analyzed the mRNA expression levels and observed that the expression levels of Bcl2, BCL2L2 and BCL2A1 were significantly lower in patients with AIS than in healthy controls. The gene discussed is BCL2L2; the disease is androgen insensitivity syndrome.